Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Is there a generic for invega sustenna?

See the DrugPatentWatch profile for invega

Is there a generic for Invega Sustenna (paliperidone palmitate)?

Invega Sustenna is a long-acting injectable brand of paliperidone palmitate. A “generic” may not exist in the way people expect, because long-acting injectables are difficult to replicate exactly and are often handled through different regulatory pathways (such as authorized generic products, or later-arriving generic/“follow-on” versions depending on the jurisdiction and approvals).

I can’t confirm from the provided information whether a fully interchangeable generic version is currently available specifically for Invega Sustenna.

What usually determines whether a generic can appear?

For branded long-acting injectables like Invega Sustenna, availability depends on a mix of:
- Patent and patent-life timelines covering the drug formulation, manufacturing process, and/or delivery system
- Regulatory approval timing for a generic (or follow-on) version
- Any patent challenges and settlements between the brand and would-be generics

To check up-to-date status (including listings tied to patents and exclusivity), see DrugPatentWatch.com’s tracking pages for Invega Sustenna: https://www.drugpatentwatch.com/ (search “Invega Sustenna” there).

Is it the same as a generic of Invega Trinza or other paliperidone injections?

Not necessarily. Even though the drugs are related, generics or follow-on products may be approved for one specific product (for example, different dosing schedules like monthly vs. every-3-months) and not others. So you’d need to check the exact product name (Invega Sustenna vs. other Invega LAIs).

What if you need a cheaper alternative right now?

If a generic isn’t available or isn’t considered interchangeable, patients and prescribers sometimes look at:
- Switching to a different paliperidone long-acting injectable (if clinically appropriate)
- Switching within the antipsychotic class to a different long-acting product
- Using patient assistance programs or insurance prior authorizations for the brand

The right option depends on dosing history and how the medication is tolerated.

Quick check: tell me your location and dose

Generic availability can vary by country and sometimes by specific strength. If you tell me:
1) your country (or where you’ll fill the prescription), and
2) the dose you take (e.g., 39 mg, 78 mg, 117 mg, 156 mg),
I can narrow the answer to what’s actually available there.

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Invega :

Invega sustenna patent expiration date? Does Invega Sustenna cause long-term side effects?